Beibei Wu

1.7k total citations
47 papers, 1.3k citations indexed

About

Beibei Wu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Beibei Wu has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Beibei Wu's work include Advanced Glycation End Products research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Cancer-related gene regulation (4 papers). Beibei Wu is often cited by papers focused on Advanced Glycation End Products research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Cancer-related gene regulation (4 papers). Beibei Wu collaborates with scholars based in China, United States and Poland. Beibei Wu's co-authors include Steve P. Crampton, Christopher C.W. Hughes, Marian L. Waterman, Wei Yan, Beidou Xi, Xiaojie Sun, Rongqiao He, Chanshuai Han, Xiaoou Shan and Tingting Xu and has published in prestigious journals such as Immunity, PLoS ONE and Biomaterials.

In The Last Decade

Beibei Wu

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beibei Wu China 21 666 139 138 118 117 47 1.3k
Yujin Zhang China 23 621 0.9× 154 1.1× 98 0.7× 92 0.8× 97 0.8× 63 1.7k
Fei Feng China 21 910 1.4× 126 0.9× 235 1.7× 136 1.2× 137 1.2× 115 2.1k
Haiyan Lu China 23 779 1.2× 170 1.2× 150 1.1× 62 0.5× 123 1.1× 81 1.7k
Yu Gui Canada 20 459 0.7× 95 0.7× 127 0.9× 58 0.5× 93 0.8× 55 1.2k
Rebeca López‐Marure Mexico 25 483 0.7× 129 0.9× 99 0.7× 57 0.5× 131 1.1× 73 1.6k
Jung Sun Heo South Korea 27 913 1.4× 85 0.6× 114 0.8× 94 0.8× 118 1.0× 69 1.9k
Hailong Hu China 20 444 0.7× 90 0.6× 107 0.8× 72 0.6× 67 0.6× 82 1.3k
Ji Won Kim South Korea 23 626 0.9× 103 0.7× 65 0.5× 50 0.4× 150 1.3× 66 1.5k

Countries citing papers authored by Beibei Wu

Since Specialization
Citations

This map shows the geographic impact of Beibei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Wu more than expected).

Fields of papers citing papers by Beibei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beibei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Wu. The network helps show where Beibei Wu may publish in the future.

Co-authorship network of co-authors of Beibei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Beibei Wu. A scholar is included among the top collaborators of Beibei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beibei Wu. Beibei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Beibei, Yanyan Xu, Yajun Wu, et al.. (2025). Low temperature hydrochar from sewage sludge enhancing polyacrylamide-based preformed particle gels with high temperature and salinity tolerance. Journal of Water Process Engineering. 76. 108282–108282. 2 indexed citations
2.
Yang, Fan, Beibei Wu, Jiahao Chen, et al.. (2024). Photo-controlled multifunctional hydrogel for photothermal sterilization and microenvironment amelioration of infected diabetic wounds. Journal of Controlled Release. 377. 470–484. 6 indexed citations
4.
Wu, Beibei, et al.. (2022). Age-related adiposity and beta-cell function: impact on prediabetes and diabetes prevalence in middle-aged and older Han Chinese adults. Journal of Endocrinological Investigation. 46(2). 405–413. 4 indexed citations
5.
Wu, Beibei, et al.. (2022). Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury. Journal of Controlled Release. 349. 401–412. 30 indexed citations
6.
Xi, Beidou, et al.. (2022). Methane Emission Reduction and Biological Characteristics of Landfill Cover Soil Amended With Hydrophobic Biochar. Frontiers in Bioengineering and Biotechnology. 10. 905466–905466. 32 indexed citations
7.
Wu, Beibei, et al.. (2021). Transthyretin contributes to insulin resistance and diminishes exercise-induced insulin sensitivity in obese mice by inhibiting AMPK activity in skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism. 320(4). E808–E821. 8 indexed citations
8.
Xu, Yingying, Beibei Wu, Xi Cao, et al.. (2021). Extended-release of therapeutic microRNA via a host-guest supramolecular hydrogel to locally alleviate renal interstitial fibrosis. Biomaterials. 275. 120902–120902. 23 indexed citations
9.
Yan, Tao, Zongming Song, Shilong Ying, et al.. (2021). MD2 blockade prevents modified LDL-induced retinal injury in diabetes by suppressing NADPH oxidase-4 interaction with Toll-like receptor-4. Experimental & Molecular Medicine. 53(4). 681–694. 11 indexed citations
10.
Zhou, Jianhong, Beibei Wu, Wu Zheng, et al.. (2019). Accumbal Adenosine A2A Receptors Enhance Cognitive Flexibility by Facilitating Strategy Shifting. Frontiers in Cellular Neuroscience. 13. 130–130. 7 indexed citations
11.
Zhang, Yali, Beibei Wu, Hailing Zhang, et al.. (2017). Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine. 22(2). 936–947. 23 indexed citations
12.
Wu, Beibei, Liying Wang, Ting Dong, et al.. (2017). Identification of a novel DMD duplication identified by a combination of MLPA and targeted exome sequencing. Molecular Cytogenetics. 10(1). 8–8. 5 indexed citations
13.
Zhang, Yali, Jianzhang Wu, Shilong Ying, et al.. (2016). Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury. Scientific Reports. 6(1). 25130–25130. 51 indexed citations
14.
Zhang, Yali, Zhiguo Feng, Tingting Xu, et al.. (2016). A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo. Drug Design Development and Therapy. Volume 10. 1947–1959. 12 indexed citations
15.
Tong, Zhiqian, Chanshuai Han, Min Qiang, et al.. (2014). Age-related formaldehyde interferes with DNA methyltransferase function, causing memory loss in Alzheimer's disease. Neurobiology of Aging. 36(1). 100–110. 81 indexed citations
16.
Han, Chanshuai, Yang Lü, Wei Yan, et al.. (2014). D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation. Cell Death and Disease. 5(3). e1117–e1117. 44 indexed citations
17.
Wu, Beibei, et al.. (2013). Ring Finger Protein 14 is a new regulator of TCF/β‐catenin‐mediated transcription and colon cancer cell survival. EMBO Reports. 14(4). 347–355. 25 indexed citations
18.
Kodani, Andrew, et al.. (2010). Par6α Interacts with the Dynactin Subunit p150Gluedand Is a Critical Regulator of Centrosomal Protein Recruitment. Molecular Biology of the Cell. 21(19). 3376–3385. 47 indexed citations
19.
Crampton, Steve P., et al.. (2009). Integration of the β-Catenin-Dependent Wnt Pathway with Integrin Signaling through the Adaptor Molecule Grb2. PLoS ONE. 4(11). e7841–e7841. 57 indexed citations
20.
Syed, Adeela, Beibei Wu, Nate P. Hoverter, et al.. (2007). A Unique DNA Binding Domain Converts T-Cell Factors into Strong Wnt Effectors. Molecular and Cellular Biology. 27(23). 8352–8363. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026